Effects and persistence of denosumab in postmenopausal women with osteoporosis.

Trial Profile

Effects and persistence of denosumab in postmenopausal women with osteoporosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Oct 2015

At a glance

  • Drugs Denosumab (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Dec 2014 New trial record
    • 01 Apr 2012 Recruitment completed, according to interim results presented at 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top